ArticleChina CDC weekly2024
Epidemiological Features and Spatial-Temporal Clustering of Visceral Leishmaniasis - China, 2011-2022.
Article in China CDC weekly, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- First record of Phlebotomus sergenti (Diptera: Psychodidae) in China and its potential epidemiological implications.PLoS neglected tropical diseases · 2026Article
- Expanding mountain-type zoonotic visceral leishmaniasis in China: a multi-source data-driven investigation.The Lancet regional health. Western Pacific · 2026Article
- Regression Analysis of the Main Environmental Risk Factors for Mountainous Subtype of Zoonotic VL in China.Journal of tropical medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
What is already known about this topic?: Visceral leishmaniasis (VL), transmitted by sandflies, is a zoonotic disease of public health importance in central and western China. What is added by this report?: A number of VL hotspots were identified in the border areas of Shanxi-Hebei, Shanxi-Shaanxi, Gansu-Sichuan, as well as the southern Xinjiang provincial-level administrative division (PLAD). Mountain zoonotic visceral leishmaniasis (MT-ZVL) expanded rapidly in the mountainous regions of Shaanxi, Shanxi, Henan, Hebei, Beijing, and Gansu PLADs from 2011 to 2022. A notable resurgence of MT-ZVL has occurred, with 671 cases in 66 historically endemic counties. What are the implications for public health practice?: Actions are recommended to restrain the rapid expansion of MT-ZVL: Firstly, implement One Health approaches, such as timely diagnosis and treatment of patients, promoting insecticide-impregnated dog collars, and restraining the number of dogs in endemic areas. Secondly, surveillance-response systems for sandflies and infective dogs in potential risk areas should be strengthened.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.